Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) EBT Margin: 2009-2024

Historic EBT Margin for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to -17.08%.

  • Cumberland Pharmaceuticals' EBT Margin fell 665.00% to -23.44% in Q3 2025 from the same period last year, while for Sep 2025 it was -8.18%, marking a year-over-year increase of 2114.00%. This contributed to the annual value of -17.08% for FY2024, which is 119.00% down from last year.
  • According to the latest figures from FY2024, Cumberland Pharmaceuticals' EBT Margin is -17.08%, which was down 7.46% from -15.89% recorded in FY2023.
  • Cumberland Pharmaceuticals' EBT Margin's 5-year high stood at -13.29% during FY2022, with a 5-year trough of -17.55% in FY2020.
  • Over the past 3 years, Cumberland Pharmaceuticals' median EBT Margin value was -15.89% (recorded in 2023), while the average stood at -15.42%.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' EBT Margin spiked by 947bps in 2020 and then slumped by 261bps in 2023.
  • Cumberland Pharmaceuticals' EBT Margin (Yearly) stood at -17.55% in 2020, then surged by 209bps to -15.46% in 2021, then surged by 217bps to -13.29% in 2022, then slumped by 261bps to -15.89% in 2023, then plummeted by 119bps to -17.08% in 2024.